Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Therapeutic potential of mesenchymal stem cells for severe acute lung injury.

Matthay MA, Thompson BT, Read EJ, McKenna DH Jr, Liu KD, Calfee CS, Lee JW.

Chest. 2010 Oct;138(4):965-72. doi: 10.1378/chest.10-0518. Review.

2.

Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases.

Monsel A, Zhu YG, Gudapati V, Lim H, Lee JW.

Expert Opin Biol Ther. 2016 Jul;16(7):859-71. doi: 10.1517/14712598.2016.1170804. Epub 2016 Apr 12. Review.

3.

Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome.

Wang YY, Li XZ, Wang LB.

Stem Cell Res Ther. 2013 May 2;4(3):45. doi: 10.1186/scrt193. Review.

4.

Mesenchymal stem cells for acute lung injury: preclinical evidence.

Matthay MA, Goolaerts A, Howard JP, Lee JW.

Crit Care Med. 2010 Oct;38(10 Suppl):S569-73. doi: 10.1097/CCM.0b013e3181f1ff1d. Review.

5.

The Immunomodulatory and Therapeutic Effects of Mesenchymal Stromal Cells for Acute Lung Injury and Sepsis.

Ho MS, Mei SH, Stewart DJ.

J Cell Physiol. 2015 Nov;230(11):2606-17. doi: 10.1002/jcp.25028. Review.

PMID:
25913273
6.

Mesenchymal stromal cell injection protects against oxidative stress in Escherichia coli-induced acute lung injury in mice.

Shalaby SM, El-Shal AS, Abd-Allah SH, Selim AO, Selim SA, Gouda ZA, Abd El Motteleb DM, Zanfaly HE, El-Assar HM, Abdelazim S.

Cytotherapy. 2014 Jun;16(6):764-75. doi: 10.1016/j.jcyt.2013.12.006. Epub 2014 Feb 11.

PMID:
24525173
7.

Potential application of mesenchymal stem cells in acute lung injury.

Lee JW, Gupta N, Serikov V, Matthay MA.

Expert Opin Biol Ther. 2009 Oct;9(10):1259-70. doi: 10.1517/14712590903213651. Review.

8.

Mesenchymal stem cells in acute lung injury: are they ready for translational medicine?

Xu F, Hu Y, Zhou J, Wang X.

J Cell Mol Med. 2013 Aug;17(8):927-35. doi: 10.1111/jcmm.12063. Epub 2013 Jul 3. Review.

9.

Mesenchymal Stem Cells Overexpressing Angiotensin-Converting Enzyme 2 Rescue Lipopolysaccharide-Induced Lung Injury.

He H, Liu L, Chen Q, Liu A, Cai S, Yang Y, Lu X, Qiu H.

Cell Transplant. 2015;24(9):1699-715. doi: 10.3727/096368914X685087. Epub 2014 Oct 6.

PMID:
25291359
10.

Bone marrow-derived mesenchymal stem cells attenuate phosgene-induced acute lung injury in rats.

Chen J, Shao Y, Xu G, Lim C, Li J, Xu D, Shen J.

Inhal Toxicol. 2015;27(5):254-61. doi: 10.3109/08958378.2015.1037029. Epub 2015 May 13.

PMID:
25970824
11.
12.

Adult stem cells for acute lung injury: remaining questions and concerns.

Zhu YG, Hao Q, Monsel A, Feng XM, Lee JW.

Respirology. 2013 Jul;18(5):744-56. doi: 10.1111/resp.12093. Review.

13.

Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review.

McIntyre LA, Moher D, Fergusson DA, Sullivan KJ, Mei SH, Lalu M, Marshall J, Mcleod M, Griffin G, Grimshaw J, Turgeon A, Avey MT, Rudnicki MA, Jazi M, Fishman J, Stewart DJ; Canadian Critical Care Translational Biology Group.

PLoS One. 2016 Jan 28;11(1):e0147170. doi: 10.1371/journal.pone.0147170. eCollection 2016. Review.

14.

Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice.

Zhu YG, Feng XM, Abbott J, Fang XH, Hao Q, Monsel A, Qu JM, Matthay MA, Lee JW.

Stem Cells. 2014 Jan;32(1):116-25. doi: 10.1002/stem.1504.

15.

Mesenchymal stem cells and acute lung injury.

Gotts JE, Matthay MA.

Crit Care Clin. 2011 Jul;27(3):719-33. doi: 10.1016/j.ccc.2011.04.004. Epub 2011 May 23. Review.

16.

Concise review: Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors.

Lee JW, Fang X, Krasnodembskaya A, Howard JP, Matthay MA.

Stem Cells. 2011 Jun;29(6):913-9. doi: 10.1002/stem.643. Review.

17.

Stem cell therapy for acute respiratory distress syndrome: a promising future?

Horie S, Masterson C, Devaney J, Laffey JG.

Curr Opin Crit Care. 2016 Feb;22(1):14-20. doi: 10.1097/MCC.0000000000000276. Review.

PMID:
26645555
18.

Intrapulmonary delivery of human umbilical cord mesenchymal stem cells attenuates acute lung injury by expanding CD4+CD25+ Forkhead Boxp3 (FOXP3)+ regulatory T cells and balancing anti- and pro-inflammatory factors.

Sun J, Han ZB, Liao W, Yang SG, Yang Z, Yu J, Meng L, Wu R, Han ZC.

Cell Physiol Biochem. 2011;27(5):587-96. doi: 10.1159/000329980. Epub 2011 Jun 15.

19.

Acute lung injury: epidemiology, pathogenesis, and treatment.

Johnson ER, Matthay MA.

J Aerosol Med Pulm Drug Deliv. 2010 Aug;23(4):243-52. doi: 10.1089/jamp.2009.0775. Review.

20.

Paracrine factors from mesenchymal stem cells: a proposed therapeutic tool for acute lung injury and acute respiratory distress syndrome.

Li J, Huang S, Wu Y, Gu C, Gao D, Feng C, Wu X, Fu X.

Int Wound J. 2014 Apr;11(2):114-21. doi: 10.1111/iwj.12202. Epub 2013 Dec 26. Review.

PMID:
24373614

Supplemental Content

Support Center